Shire Loses Fed. Circ. Appeal In Generic Infringement Suit
A Federal Circuit panel cleared the way Tuesday for generic-drug maker Zydus to bring its version of Shire PLC's gastrointestinal drug Lialda to market, shooting down Shire's argument that a lower...To view the full article, register now.
Already a subscriber? Click here to view full article